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Heart failure (HF) is a common condition in Zambian 
hospitals, causing substantial morbidity and mortality. 
There has been a reported greater propensity for heart 
failure in blacks which may be related to a genetic 
predisposition to cardiomyopathy, higher prevalence of 
risk factors such as hypertension and exposure to toxins 
1such as alcohol . Much less is known of heart failure in 
Zambians and it is therefore gratifying to note the paper 
2by P.Chansa et al documenting factors that relate to 
mortality in this group of patients at the University 
Teaching Hospital in Lusaka.Indeed an understanding of 
the etiological factors and subsequent pathophysiological 
manifestations have a bearing on the rational approaches 
to diagnosis and management, and an appreciation of the 
factors that influence mortality, will definitely enhance 
evidence based clinical practice and improve health 
outcomes.  
The definition of heart failure
Heart failure broadly refers to a clinical syndrome 
resulting from an inadequate cardiac output or from a 
state where  the cardiac output is sustained by an 
increased filling pressure. This manifests in signs and 
symptoms of low cardiac output, pulmonary congestion 
and systemic venous congestion. It is therefore a vague 
and imprecise descriptive term rather than a definitive 
diagnosis. In its milieu of manifestations, good clinical 
outcomes are dependent on more accurate diagnosis and 
precise therapeutic interventions aimed at not only 
reducing mortality, but also on improving quality of life.
Patho-aetiology of Heart Failure
This study indicates a young population of sufferers of HF 
in Zambia, confirming the observation made elsewhere 
1about HF in the black population . There is urgency to 
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clearly elucidate the pathoeatiology to mitigate this state 
of affairs. Indeed this study population had a good amount 
of individuals with valvular heart disease, rheumatic heart 
disease (RHD) being a significant contributor, and 
hypertension. It is time to increase RHD and 
Hypertension prevention interventions. 
The related finding was that of dilated cardiomyopathy, 
whose aetiology is not known but assumed to be infective. 
However, HIV infection was not found to be a significant 
confounder in this case.However, this needs further 
detailing. The HIV cardiomyopathy, a dilated, low output 
cardiomyopathy was described in as early as 1986 by 
3Cohen and colleagues and reported to be a result of a viral 
myocarditis. Indeed the prevalence of HIV in this study 
population was higher (23%) than that found in the 
general population (14.1%). The significance of this 
finding begs for answers especially that it is reported that 
clinical heart muscle disease and heart failure in AIDS is 
4unusual . The contribution of anti-retroviral therapy and 
other drugs including alcohol to the causation of heart 
failure was not specifically explored in this study. Neither 
were vitamin and selenium deficiencies nor cachexia 
investigated as aetiological factors for the 
cardiomyopathies.
Echocardiography in clinical practice
This study also underlines the importance of 
echocardiography in the description and comprehensive 
management of HF and negates the reflex prescription of 
inotropic agents for all types of HF. There were about as 
many HF patients with preserved ejection fraction 
(HFpEF) as there were those HF patients with reduced EF 
(HFrEF). This index alone desegregated the subjects 
etiologically; those with HFpEF having had HHD, cor-
pulmonale or valvular heart disease (VHD) while a 
majority with HFrEF had dilated cardiomyopathy. The 
approach to management of these conditions is very 
varied and crucial for better clinical outcomes. HFpEF is 
mostly a result of diastolic failure manifesting as 
abnormal left ventricular relaxation and increased left 
ventricular chamber stiffness while HFrEF is mostly a 
resul t  of  sys to l ic  dysfunct ion.  Indeed,  an  
echocardiograph ought to be a common diagnostic tool at 
the hands of the clinicians to aid evidence based 
approaches to management. Without it, management is 
likely to be a result of “informed guess work” with 
relatively poor outcomes. 
Electrocardiography in clinical practice
Arrhythmias and conduction defects are quite common in 
HF, the most common being Atrial Fibrillation  (AF) 
which has serious consequences.  In the study, 8% of 
patients had AF and few other arrhythmias are described. 
The limitations outlines by the authors are appreciated. 
Indeed, the lack of electrocardiographic ambulatory 
(holter) monitoring facilities at the UTH makes diagnosis 
of paroxysmal AF/arrhythmia difficult meaning that the 
reported figure is most likely an underestimate. 
Arrhythmias predispose to thromboembolic events and 
may require anticoagulation in addition to the other 
therapies .  This  demonstra tes  the  need for  
electrocardiography to be a routine, readily available and 
easily accessible diagnostic tool as well in the 
management of HF.
Anaemia and iron deficiency in HF
The role of anaemia in morbidity and mortality of patients 
with HF has again been highlighted in this paper. It has 
been shown that anemia is an independent prognostic 
determinant for mortality. Indeed it has been said that low 
level of ferritin, rather than gross anaemia, is the better 
5prognostic indicator . Iron deficiency is said to develop in 
HF patients due to depletion of iron stores, iron 
malabsorption and reduced availability of iron recycledin 
6,7the reticuloendothelial system . Indeed, correction of 
iron deficiency with the use of intravenous iron in patients 
8with chronic heart failure has had clinical benefits . This 
is another wake up call to diligence in evaluating HF 
patients for holistic care and management. Quality care 
would demand for measurement of serum ferritin in all 
patients of HF although Hb would be a proxy.
The kidney in Heart Failure
The ongoing physiological interactions between the 
cardiovascular and renal systems are well demonstrated 
in HF. While the initial intentions for these interactions is 
for homeostasis, the inability to sustain this constancy in 
the 'internal milieu' is indicative of the severity of the 
underlying pathology. There is evidently activation of the 
Renin-Angiotensin-Aldosterone system while 
stimulating the renal sympathetic neural systems that 
negatively impact on the physiological mechanisms 
responsible for optimal cardiac output and electrolyte 
balance. The study reported that a high serum urea and 
high creatinine were prognostic indicators for poor 
outcome. Several electrolyte derangements are reported 
in HF, again highlighting the importance of clinical 
chemistry investigations for optimal management of HF.  
Mortality from Heart failure at the UTH
A mortality of 35% reported in the paper is among the 
highest in the world. It calls for a serious and urgent 
evaluation of all clinical care delivery systems to achieve 
optimal results. Indeed the findings of this study provide 
a good platform from which to launch remedial measures 
supported by evidence. There is definitely evidence for 
sub-optimal evaluation of patients with HF and lack of 
guidelines for management of HF. There was very low 
utilization of â-blockers, diuretics  and angiotensin-
converting-enzyme inhibitors in certain groups of 
patients who may have benefited from these therapies. 
However, the decisions for specific cost-effective 
therapeutic interventions depend on diagnostic accuracy 
and evidence from the prognostic indicators. 
Conclusion
There is indeed an epidemic of HF in the midst of the 
Non-communicable diseases (NCD) epidemic 
necessitating timely responses to mitigate against 
mortality. The evidence presented unmasks much that 
was not known of HF at the UTH and surely provides 
evidence for alteration of clinical practice for better 
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health outcomes. It is time to move towards formulating 
practice guidelines and protocols to regulate management 
of HF while facilitating provision of basic diagnostic 
tools in the health facilities to improve clinical outcomes. 
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